OTCMKTS:MPSYF

MorphoSys (MPSYF) Stock Price, News & Analysis

MorphoSys logo
$73.27 0.00 (0.00%)
As of 11/6/2026

About MorphoSys Stock (OTCMKTS:MPSYF)

Advanced

Key Stats

Today's Range
$73.27
▼
$73.27
50-Day Range
$73.27
▼
$73.27
52-Week Range
$71.76
▼
$73.27
Volume
N/A
Average Volume
1,800 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MorphoSys AG was a German biopharmaceutical company focused on developing antibody-based medicines, particularly for cancer and blood disorders. Founded in 1992 and headquartered in Planegg, Germany, it also developed antibody-discovery technologies and partnered with other pharmaceutical companies.

Its best-known medicine was tafasitamab, marketed as Monjuvi in the United States and Minjuvi in Europe. Developed with Incyte, the antibody was used with other treatment for certain adults with relapsed or refractory diffuse large B-cell lymphoma. MorphoSys also advanced an oncology pipeline that included pelabresib.

Novartis acquired MorphoSys in 2024, bringing the company’s medicines and research programs into its pharmaceutical business. MorphoSys is therefore no longer an independent operating company.

AI Generated. May Contain Errors.

Receive MPSYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MPSYF Stock News Headlines

MorphoSys AG (MPSYF)
See More Headlines

MPSYF Stock Analysis - Frequently Asked Questions

MorphoSys' stock was trading at $73.27 at the start of the year. Since then, MPSYF stock has increased by 0.0% and is now trading at $73.27.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MPSYF
CIK
1340243
Fax
N/A
Employees
730
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (OTCMKTS:MPSYF) was last updated on 11/6/2026 by MarketBeat.com Staff.
From Our Partners